Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA)

被引:125
|
作者
Coperchini, F. [1 ]
Awwad, O. [2 ]
Rotondi, M. [1 ]
Santini, F. [3 ]
Imbriani, M. [4 ]
Chiovato, L. [1 ]
机构
[1] Univ Pavia, Salvatore Maugeri IRCCS, Lab Endocrine Disruptors Fdn, Unit Internal Med & Endocrinol,Chair Endocrinol, Via Maugeri 10, I-27100 Pavia, Italy
[2] Univ Jordan, Dept Biopharmaceut & Clin Pharm, Amman, Jordan
[3] Univ Hosp Pisa, Dept Clin & Expt Med, Endocrinol Unit 1, Pisa, Italy
[4] Univ Pavia, Dept Publ Hlth Expt & Forens Med, Pavia, Italy
关键词
PFOA; PFOS; Thyroid; SPRAGUE-DAWLEY RATS; DECANOIC ACID PFDA; PERFLUORINATED COMPOUNDS; PERFLUOROALKYL SUBSTANCES; AMMONIUM PERFLUOROOCTANOATE; PLACENTAL-TRANSFER; COHORT MORTALITY; PREGNANT-WOMEN; HORMONE LEVELS; PPAR-ALPHA;
D O I
10.1007/s40618-016-0572-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) are two fluorinated compounds widely used in industry because of their useful chemical characteristics. They were identified as endocrine disruptors due to their ability to interfere with thyroid function. The resistance of PFOA and PFOS to environmental degradation, their bio-accumulation in food chains, and their long half-life raised concern in the scientific community, and several studies were performed with the aim to establish the real dangerousness of these compounds for the human health. Purpose The present review will focus on the effects of PFOA and PFOS on the thyroid gland taking into account in vitro experiments, animal studies, and human data. PFOS and PFOA reduce the circulating levels of thyroid hormones in diet-exposed animals, mainly by increasing their metabolic clearance rate. Conclusions An accumulation of PFOS and PFOA was documented in thyroid cells, and a cytotoxic effect was observed after exposure to extremely high concentrations of these compounds. In environmentally exposed communities and in the general population, the most consistent effect of exposure to PFOA, and to a less extent to PFOS, is the occurrence of hypothyroidism. Women and children appear to be more at risk of developing mild thyroid failure. Pregnant women with circulating thyroid antibodies might be at risk of developing subclinical hypothyroidism, mainly when exposed at high doses of PFOS. The relative risks for thyroid cancer in people exposed to PFOA and PFOS were low and based on a few cases. Moreover, there was no consistent finding across all or even most studies.
引用
收藏
页码:105 / 121
页数:17
相关论文
共 50 条
  • [1] Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA)
    F. Coperchini
    O. Awwad
    M. Rotondi
    F. Santini
    M. Imbriani
    L. Chiovato
    [J]. Journal of Endocrinological Investigation, 2017, 40 : 105 - 121
  • [2] Partitioning of perfluorooctanoate (PFOA), perfluorooctane sulfonate (PFOS) and perfluorooctane sulfonamide (PFOSA) between water and sediment
    Ahrens, Lutz
    Yeung, Leo W. Y.
    Taniyasu, Sachi
    Lam, Paul K. S.
    Yamashita, Nobuyoshi
    [J]. CHEMOSPHERE, 2011, 85 (05) : 731 - 737
  • [3] Occurrence of Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoate(PFOA) in Aquatic Systems from Asia
    Xu, Xiao-Lu
    Xu, Hui-Ying
    Zhang, De-Yong
    Shen, Xiu-ying
    Tong, Guo-Zhang
    Lu, Yin
    Wang, Wei
    [J]. PROGRESS IN ENVIRONMENTAL PROTECTION AND PROCESSING OF RESOURCE, PTS 1-4, 2013, 295-298 : 513 - +
  • [4] Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) and their associations with human semen quality measurements
    Raymer, James H.
    Michael, Larry C.
    Studabaker, William B.
    Olsen, Geary W.
    Sloan, Carol S.
    Wilcosky, Timothy
    Walmer, David K.
    [J]. REPRODUCTIVE TOXICOLOGY, 2012, 33 (04) : 419 - 427
  • [5] Comparative study on adsorption of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) by different adsorbents in water
    Yao, Yuan
    Volchek, Konstantin
    Brown, Carl E.
    Robinson, Adam
    Obal, Terry
    [J]. WATER SCIENCE AND TECHNOLOGY, 2014, 70 (12) : 1983 - 1991
  • [6] Serum Perfluorooctanoate (PFOA) and Perfluorooctane Sulfonate (PFOS) Concentrations and Liver Function Biomarkers in a Population with Elevated PFOA Exposure
    Gallo, Valentina
    Leonardi, Giovanni
    Genser, Bernd
    Lopez-Espinosa, Maria-Jose
    Frisbee, Stephanie J.
    Karlsson, Lee
    Ducatman, Alan M.
    Fletcher, Tony
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2012, 120 (05) : 655 - 660
  • [7] Removal of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) from water by coagulation: Mechanisms and influencing factors
    Bao, Yueping
    Niu, Junfeng
    Xu, Zesheng
    Gao, Ding
    Shi, Jianghong
    Sun, Xiaomin
    Huang, Qingguo
    [J]. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2014, 434 : 59 - 64
  • [8] Recovery of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) from dilute water solution by foam flotation
    Lee, Yu-Chi
    Wang, Po-Yen
    Lo, Shang-Lien
    Huang, C. P.
    [J]. SEPARATION AND PURIFICATION TECHNOLOGY, 2017, 173 : 280 - 285
  • [9] Sonochemical Degradation of Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoate (PFOA) in Landfill Groundwater: Environmental Matrix Effects
    Cheng, Jie
    Vecitis, Chad D.
    Park, Hyunwoong
    Mader, Brian T.
    Hoffmann, Michael R.
    [J]. ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2008, 42 (21) : 8057 - 8063
  • [10] Perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in soil and groundwater around a former fluoropolymer manufacturing facility
    Xiao, Feng
    Simcik, Matt F.
    Halbach, Thomas R.
    Gulliver, John S.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248